Page last updated: 2024-09-04

ivabradine and Neoplasms

ivabradine has been researched along with Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kavtaradze, N; Saganelidze, K1
Arboscello, E; Balbi, M; Bighin, C; Brunelli, C; Ghigliotti, G; Gualandi, F; Murialdo, R; Sarocchi, M; Sicbaldi, V; Spallarossa, P1
Armenian, SH; Ehrhardt, MJ; Fulbright, JM1

Reviews

1 review(s) available for ivabradine and Neoplasms

ArticleYear
[MODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF HEART FAILURE, AS A MANIFESTATION OF ANTHRACYCLINE CARDIOTOXICITY (REVIEW)].
    Georgian medical news, 2018, Issue:278

    Topics: Anthracyclines; Antineoplastic Agents; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Echocardiography; Elapid Venoms; Heart; Heart Failure; Humans; Ivabradine; Natriuretic Peptide, C-Type; Neoplasms; Survival Analysis; Trastuzumab; Trimetazidine; Troponin I

2018

Other Studies

2 other study(ies) available for ivabradine and Neoplasms

ArticleYear
Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction.
    Chemotherapy, 2018, Volume: 63, Issue:6

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anthracyclines; Cardiovascular Agents; Dose-Response Relationship, Drug; Fatigue; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Neoplasms; Retrospective Studies; Trastuzumab; Ventricular Dysfunction, Left

2018
Screening and intervention for treatment-related cardiac dysfunction in childhood cancer survivors.
    Future oncology (London, England), 2015, Volume: 11, Issue:14

    Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Biomarkers; Cardiovascular Diseases; Child; Echocardiography; Guidelines as Topic; Humans; Ivabradine; Neoplasms; Survivors; Troponin I; Troponin T

2015